Latest Exact Sciences News & Updates

See the latest news and media coverage for Exact Sciences. We track all announcements, press releases, and industry mentions in real time, all in one place.

Exact Sciences

Cancer prevention, screening, and therapy guidance company

exactsciences.com

Headquarters: Madison, United States
Company type: Public company
Number of employees: 5,000–10,000
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Exact Sciences

In short: Exact Sciences was acquired by Abbott Laboratories for $23 billion and reported record annual revenue despite experiencing a cyber attack.

Company announcements

July 7 Exact Sciences

Exact Sciences expands Cancerguard test access in Japan

The multi-cancer early detection test is now available to patients in Japan following a team effort.

February 13 Exact Sciences

Exact Sciences achieves record 2025 revenue

Revenue grew 18% to $3.25B, with Screening and Precision Oncology both strong.

February 3 Exact Sciences

Exact Sciences' Oncotype DX test surpasses two million patients worldwide

The milestone underscores its role as a global standard-of-care, helping an estimated 1.6 million patients avoid potentially unnecessary chemotherapy.

February 2 Exact Sciences

Exact Sciences applauds passage of MCED coverage legislation

The law establishes a Medicare coverage pathway for multi-cancer early detection tests, potentially expanding access to Cancerguard for millions.

Media coverage

September 7 Ad hoc news

Exact Sciences stock edges higher after solid growth and cautious outlook

Exact Sciences stock trades slightly higher as investors digest ongoing revenue growth and a cautious outlook on profitability and competition in cancer diagnostics. Exact Sciences...

August 20 Yahoo Finance

Jefferies sets strong price target on upstart cancer stock

Jefferies just initiated coverage on a small cancer-screening stock, and the target price points to...

August 17 Wisconsin State Journal

Abbott Labs to acquire Madison's Exact Sciences in $23 billion deal

The company will maintain its presence in Madison and CEO Kevin Conroy will remain "in an advisory role," said Zach Brandon, president of the Greater...

August 3 Wisconsin State Journal

Exact Sciences' cancer-detecting blood tests could be covered by Medicare under new federal law

Exact Sciences' Cancerguard, a blood-based early detection test, is not covered by insurance and costs patients $689 out of pocket. But future Medicare coverage could...

Never miss news about Exact Sciences

Track Exact Sciences and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Exact Sciences competitors & trending companies

Browse news for competitors to Exact Sciences and other trending companies.